Microbiome Sequencing Services Market by Technology (Sequencing by Synthesis), Application (RNA Sequencing), Research Type (Outsourcing), Laboratory Type (Wet Lab, Dry Lab), End User (Pharmaceutical & Biotechnology), Other Technologies - Forecast to 2021
[121 Pages Report] The global microbiome sequencing services market is poised to reach USD 1,424.7 Million by 2021 from USD 538.0 Million in 2016, at a CAGR of 21.5% from 2016 to 2021.
In this report, the global market is broadly segmented by technology, application, research type, laboratory type, end user, and region. On the basis of technology, the market is divided into sequencing by synthesis (SBS), sequencing by ligation (SBL), pyrosequencing, sanger sequencing, and other technologies (such as Omic technologies). The sequencing by synthesis segment is expected to grow at the highest CAGR of the market in 2016.
The market by application is broadly classified into shotgun sequencing, targeted gene sequencing, RNA sequencing, whole genome sequencing, and other applications (such as small molecule analysis and protein analysis). The shotgun sequencing segment is estimated to grow at the highest CAGR and the highest share of the market during the forecast period.
By laboratory type, the market is broadly divided into wet labs and dry labs. The wet labs research segment is expected to command the highest CAGR in the market in 2016.
Furthermore, on the basis of research type, the market is broadly divided into internal research and outsourced research. The outsourced research segment is expected to command the highest CAGR as well as the largest share of the market in 2016. This largest share and fastest CAGR is attributed to the increasing outsourcing R&D activities.
Based on end users, the global market is categorized into pharmaceutical and biotechnology companies and academic/research institutes. The pharmaceutical and biotechnology companies segment is expected to grow at the highest CAGR in the market in 2016.
The growth of this market is propelled by the increase in use of microbiomes in genomics, proteomics, and metabolomics and technological advancements in next-generation sequencing (NGS). On the other hand, lack of detailed research, government regulations, and ethical & legal issues related to NGS are the major factors restraining the growth of market.
Stakeholders
- Probiotic and prebiotic manufacturers
- Distributors and suppliers of microbiome-based products
- Research & consulting firms
- Drug manufacturers, suppliers, and distributors
- Pharmaceutical and biotechnology companies
- Contract research organizations (CROs)
- Microbiome service providers
To know about the assumptions considered for the study, download the pdf brochure
Scope of the Report
Particular |
Scope |
|
Region |
|
|
Historical Years |
2014 |
|
Base Year |
2015 |
|
Estimated Year |
2016-e |
|
Forecast Period |
2016-e2021-p |
|
Revenue Currency |
USD ($) |
Market Segmentation
This research report categorizes the microbiome sequencing services market on the basis of technology, application, research type, laboratory type, end user, and region.
Global Microbiome Sequencing Services, by Technology
- Sequencing by Synthesis (SBS)
- Sequencing by Ligation (SBL)
- Pyrosequencing
- Sanger Sequencing
- Other Technologies (Omic Technologies)
Global Microbiome Sequencing Services, by Application
- Shotgun Sequencing
- Targeted Gene Sequencing
- RNA Sequencing
- Whole Genome Sequencing
- Other Applications (Protein analysis and small molecule analysis)
Global Microbiome Sequencing Services, by Research Type
- Outsourced Research
- Internal Research
Global Microbiome Sequencing Services, by Laboratory Type
- Dry labs
- Wet Labs
Global Microbiome Sequencing Services, by End User
- Pharmaceutical and Biotechnology Companies
- Academia/Research Institute
Global Microbiome Sequencing Services, by Region
- North America
- Europe
- Asia-Pacific
- Rest of the World (RoW)
In this report, the global market is broadly segmented by technology, application, research type, laboratory type, end user, and region.
Major factors fueling market growth are the rising use of microbiomes in genomics, proteomics, and metabolomics and technological advancements in next-generation sequencing (NGS). On the other hand, lack of detailed research, government regulations, and ethical & legal issues related to NGS are the major factors restraining the market.
On the basis of technology, the market is divided into sequencing by synthesis (SBS), sequencing by ligation (SBL), pyrosequencing, sanger sequencing, and other technologies (such as Omic technologies). The sequencing by synthesis segment is expected to grow at the highest CAGR in the market in 2016. This growth rate can be attributed to the prevalent high demand for this technology.
Based on application, the market is segmented into shotgun sequencing, targeted gene sequencing, RNA sequencing, whole genome sequencing, and other applications (such as small molecule analysis and protein analysis). The shotgun sequencing segment is estimated to command the largest share in the market. This large share is attributed to shotgun sequencing being faster and less expensive than other methods.
By research type, the market is divided into internal research and outsourced research. The outsourced research segment is expected to command the largest share as well as the fastest CAGR in the market in 2016. This largest share and fastest CAGR is primarily due to increase in outsourced R&D services, as they are less expensive.
On the basis of laboratory type, the market is broadly divided into wet labs and dry labs. The wet labs research segment is expected to command the fastest CAGR in the market in 2016.
Based on end user, the market is broadly divided into pharmaceutical and biotechnology companies, and academic/research institutes. The pharmaceutical and biotechnology companies segment is expected to grow at the highest CAGR in the market in 2016.
North America is expected to have the highest CAGR in the global microbiome sequencing services in 2016. Factors such as favorable business environment, government support through funds for genomics research, continuous developments in sequencing technologies, availability of commercial solutions for NGS data analysis, growing number of research studies on cancer & inherited rare diseases drive the growth of the market in this region.
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
Table of Contents
1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.4 Geographic Scope
1.5 Years Considered for the Study
1.6 Currency
1.7 Limitations
1.8 Stakeholders
2 Research Methodology
2.1 Research Data
2.1.1 Key Data From Secondary Sources
2.1.2 Key Data From Primary Sources
2.2 Market Breakdown and Data Triangulation Method
2.3 Market Size Estimation
3 Executive Summary
3.1 Global Market
3.2 Global Market, By Technology
3.3 Global Market, By Application
3.4 Global Market, By Research Type
3.5 Global Market, By Laboratory Type
3.6 Global Market, By End User
3.7 Global Market, By Region
4 Premium Insights
4.1 Global Microbiome Sequencing Services: Market Overview
4.2 Geographic Analysis: Market, By Application (2016)
4.3 Global Market, By Technology, 2016 vs 2021
4.4 Global Market, By Research Type, 2016 vs 2021
4.5 Global Market, By Laboratory Type, 2016 vs 2021
4.6 Global Market, By End User, 2016 vs 2021
4.7 Geographical Snapshot of the Market
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increased Focus on Human Microbiome Therapy
5.2.1.2 Human Microbiome as New Validated Target for Drug Development
5.2.1.3 Human Microbiome for Early Disease Detection and Diagnosis
5.2.2 Restraints
5.2.2.1 Lack of Expertise and Detailed Research
5.2.2.2 Barriers in Proving the Causal Link Between Dysbiosis and Disease
5.2.3 Opportunities
5.2.3.1 Investigational New Drug (IND) Requirements for Fecal Microbiota
5.2.3.2 Increasing Collaborations Create Growth Opportunities
5.2.4 Challenge
5.2.4.1 Government Regulations
5.2.5 Burning Issues
5.2.5.1 Abundant Opportunities in the Human Microbiome Field and Tremendous Research Investments
5.2.5.2 Development of Human Microbiome Therapeutic Products
5.3 Market: Patents
5.4 Market: Funding
6 Human Microbiome Research Services Market: By Technology
6.1 Introduction
6.2 Sequencing By Synthesis (SBS)
6.3 Sequencing By Ligation (SBL)
6.4 Pyrosequencing
6.5 Sanger Sequencing
6.6 Other Technologies
7 Human Microbiome Research Services Market: By Application
7.1 Introduction
7.2 Shotgun Sequencing
7.3 Targeted Gene Sequencing
7.4 Rna Sequencing
7.5 Whole Genome Sequencing
7.6 Other Applications
8 Human Microbiome Research Services Market: By Research Type
8.1 Introduction
8.2 Outsourced
8.3 Internal
9 Human Microbiome Research Services Market: By Laboratory Type
9.1 Introduction
9.2 Wet Labs
9.3 Dry Labs
10 Human Microbiome Research Services Market: By End User
10.1 Introduction
10.2 Pharmaceutical and Biotechnology Companies
10.3 Academia/Research Institutes
11 Human Microbiome Research Services Market: By Region
11.1 Introduction
11.2 Europe
11.3 North America
11.4 Asia-Pacific
11.5 Rest of the World (RoW)
12 Competitive Landscape
12.1 Overview
12.2 Growth Strategies Adopted By Players in the Market (20142016)
13 Company Profiles
(Overview, Products and Services, Financials, Strategy & Development)*
13.1 Baseclear B.V.
13.2 Clinical-Microbiomics A/S
13.3 Molzym GmbH & Co. Kg
13.4 Zymo Research Corp.
13.5 Rancho Biosciences
13.6 Microbiome Therapeutics, LLC.
13.7 Microbiome Insights Inc.
13.8 Openbiome
13.9 Resphera Biosciences, LLC.
13.10 MR DNA (Molecular Research Lp)
13.11 Ubiome, Inc.
13.12 Shanghai Realbio Technology Co., Ltd
13.13 Diversigen, Inc.
13.14 Merieux Nutrisciences Corporation
13.15 Metabiomics Corp.
*Details on Overview, Products and Services, Financials, Strategy & Development Might Not Be Captured in Case of Unlisted Companies.
14 Appendix
14.1 Insights From Industry Experts
14.2 Discussion Guide
14.3 Knowledge Store: Marketsandmarkets Subscription Portal
14.4 Marketsandmarkets Knowledge Store: Snapshot
14.5 Introducing RT: Real Time Market Intelligence
14.6 Author Details
List of Tables (44 Tables)
Table 1 Market Size, By Technology, 2014-2021(USD Million)
Table 2 Market Size, By Laboratory Type, 2014-2021(USD Million)
Table 3 Global Market Size, By Technology, 20142021 (USDmillion)
Table 4 Market Size for SBS, By Region, 20142021 (USD Million)
Table 5 Market Size for SBL, By Region, 20142021 (USD Million)
Table 6 Market Size for Pyrosequencing, By Region, 20142021 (USD Million)
Table 7 Market Size for Sanger Sequencing, By Region, 20142021 (USD Million)
Table 8 Market Size for Other Technologies, By Region, 20142021 (USD Million)
Table 9 Global Microbiome Sequencing Services Market Size, By Application, 20142021 (USD Million)
Table 10 Market Size for Shotgun Sequencing, By Region, 20142021 (USD Million)
Table 11 Market Size for Targeted Gene Sequencing, By Region, 20142021 (USD Million)
Table 12 Market Size for Rna Sequencing, By Region, 20142021 (USD Million)
Table 13 Market Size for Whole Genome Sequencing, By Region, 20142021 (USD Million)
Table 14 Market Size for Other Application, By Region, 20142021 (USD Million)
Table 15 Global Market Size, By Research Type, 20142021 (USD Million)
Table 16 Market Size for Outsourced Research, By Region, 20142021 (USD Million)
Table 17 Market Size for Internal Research, By Region, 20142021 (USD Million)
Table 18 Global Market Size, By Laboratory Type, 20142021 (USD Million)
Table 19 Market Size for Wet Labs, By Region, 20142021 (USD Million)
Table 20 Market Size for Dry Labs, By Region, 20142021 (USD Million)
Table 21 Global Market Size, By End User, 20142021 (USD Million)
Table 22 Market Size for Pharmaceutical & Biotechnology Companies, By Region, 20142021 (USD Million)
Table 23 Market Size for Academia/Research Institutes, By Region, 20142021 (USD Million)
Table 24 Global Market Size, By Region, 20142021 (USD Million)
Table 25 Europe: Market Size, By Technology, 20142021 (USD Million)
Table 26 Europe: Market Size, By Application, 20142021 (USD Million)
Table 27 Europe: Market Size, By Research Type, 20142021 (USD Million)
Table 28 Europe: Market Size, By Laboratory Type, 20142021 (USD Million)
Table 29 Europe: Market Size, By End User, 20142021 (USD Million)
Table 30 North America: Market Size, By Technology, 20142021 (USD Million)
Table 31 North America: Market Size, By Application, 20142021 (USD Million)
Table 32 North America: Market Size, By Research Type, 20142021 (USD Million)
Table 33 North America: Market Size, By Laboratory Type, 20142021 (USD Million)
Table 34 North America: Market Size, By End User, 20142021 (USD Million)
Table 35 Asia-Pacific: Market Size, By Technology, 20142021 (USD Million)
Table 36 Asia-Pacific: Market Size, By Application, 20142021 (USD Million)
Table 37 Asia-Pacific: Market Size, By Research Type, 20142021 (USD Million)
Table 38 Asia-Pacific: Market Size, By Laboratory Type, 20142021 (USD Million)
Table 39 Asia-Pacific: Market Size, By End User, 20142021 (USD Million)
Table 40 RoW: Market Size, By Technology, 20142021 (USD Million)
Table 41 RoW: Market Size, By Application, 20142021 (USD Million)
Table 42 RoW: Market Size, By Research Type, 20142021 (USD Million)
Table 43 RoW: Market Size, By Laboratory Type, 20142021 (USD Million)
Table 44 RoW: Market Size, By Laboratory Type, 20142021 (USD Million)
List of Figures (27 Figures)
Figure 1 Research Design: Microbiome Sequencing Services Market
Figure 2 Market Size, By Technology (2016 vs 2021)
Figure 3 Market Size, By Application (2016 vs 2021)
Figure 4 Outsourced Research Segment to Register the Highest Growth During the Forecast Period
Figure 5 Market Size, By Laboratory Type (2016 vs 2021)
Figure 6 Pharmaceutical and Biotechnology Companies Segment to Register the Highest Growth During the Forecast Period
Figure 7 Market Share, By Region (2016)
Figure 8 Market to Register A High, Double-Digit CAGR in the Forecast Period
Figure 9 Shotgun Sequencing Segment to Command the Largest Market Share in 2016
Figure 10 Sequencing By Synthesis Segment to Command the Largest Market Share in 2016
Figure 11 Outsourced Research to Dominate Market in 2016
Figure 12 Wet Labs Segment to Command the Largest Market Share in 2016
Figure 13 Pharmaceutical & Biotechnology Companies to Register the Highest CAGR From 2016 to 2021
Figure 14 Europe to Dominate the Microbiome Sequencing Services Market in 2016
Figure 15 Market: Drivers, Restraints, Opportunities, and Challenges
Figure 16 Global Market Size, By Technology, 2016 vs 2021 (USD Million)
Figure 17 Market Size for SBS, By Region, 2016 vs 2021 (USD Million)
Figure 18 Global Market Size, By Application, 2016 vs 2021 (USD Million)
Figure 19 Market Share for Shotgun Sequencing, By Region, 2016 vs 2021
Figure 20 Outsourced Research to Dominate the Market for Research Type (2016)
Figure 21 Market Size for Outsourced Research, By Region, 2016 vs 2021 (USD Million)
Figure 22 Global Market Size, By Laboratory Type, 2016 vs 2021 (USD Million)
Figure 23 Market Share for Wet Labs, By Region, 2016 vs 2021
Figure 24 Global Market Size, By End User, 2016 vs 2021 (USD Million)
Figure 25 Microbiome Sequencing Services Market Size for Pharmaceutical & Biotechnology Companies, By Region, 2016 vs 2021 (USD Million)
Figure 26 Global Market Size, By Region, 2016 vs 2021 (USD Million)
Figure 27 Growth Strategies Adopted By Players in the Market (20142016)
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Microbiome Sequencing Services Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Growth opportunities and latent adjacency in Microbiome Sequencing Services Market